Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha C Nason

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|December 6, 2012
Early immunologic and virologic predictors of clinical HIV-1 disease progressionYolanda D Mahnke, Kaimei Song, Mariana M Sauer, et al.
Plos One|March 14, 2014
Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)Mary E Enama, Julie E Ledgerwood, Laura Novik, et al.
Blood|February 10, 2006
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cellsMichael R Betts, Martha C Nason, Sadie M West, et al.
Plos One|September 30, 2014
Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trialUzma N Sarwar, Laura Novik, Mary E Enama, et al.
Plos One|April 12, 2013
DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trialBarney S Graham, Mary E Enama, Martha C Nason, et al.
Plos One|February 4, 2010
Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responsesRichard A Koup, Mario Roederer, Laurie Lamoreaux, et al.
Journal of Virology|June 24, 2025
The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African womenSherazaan D Ismail, Shorok Sebaa, Bianca Abrahams, et al.
The Journal of Experimental Medicine|April 8, 2009
Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infectionDavid A Price, Tedi E Asher, Nancy A Wilson, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African womenSherazaan D Ismail, Shorok Sebaa, Bianca Abrahams, et al.
Clinical Nuclear Medicine|March 14, 2017
Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human PapillomavirusesEmily E Coates, Pamela J Costner, Martha C Nason, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|December 6, 2012
Early immunologic and virologic predictors of clinical HIV-1 disease progressionYolanda D Mahnke, Kaimei Song, Mariana M Sauer, et al.
Plos One|March 14, 2014
Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)Mary E Enama, Julie E Ledgerwood, Laura Novik, et al.
Blood|February 10, 2006
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cellsMichael R Betts, Martha C Nason, Sadie M West, et al.
Plos One|September 30, 2014
Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trialUzma N Sarwar, Laura Novik, Mary E Enama, et al.
Plos One|April 12, 2013
DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trialBarney S Graham, Mary E Enama, Martha C Nason, et al.
Plos One|February 4, 2010
Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responsesRichard A Koup, Mario Roederer, Laurie Lamoreaux, et al.
Journal of Virology|June 24, 2025
The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African womenSherazaan D Ismail, Shorok Sebaa, Bianca Abrahams, et al.
The Journal of Experimental Medicine|April 8, 2009
Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infectionDavid A Price, Tedi E Asher, Nancy A Wilson, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African womenSherazaan D Ismail, Shorok Sebaa, Bianca Abrahams, et al.
Clinical Nuclear Medicine|March 14, 2017
Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human PapillomavirusesEmily E Coates, Pamela J Costner, Martha C Nason, et al.
Pageof 7